Skip to main content

Table 3 Data and analysis France, part 1

From: Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France

Alter 2004 2050 2004 in % 2050 in % Pharma Expenses 1997 Partial Expenses 2004 Partial Expenses 2050 Change Expenses
0-9 7279,22 8658,88 12,15% 11,60% 210,44 € 25,58 € 24,41 € -4,57%
10-19 7612,54 8513,59 12,71% 11,40% 143,91 € 18,29 € 16,41 € -10,28%
20-29 7643,13 8306,88 12,76% 11,13% 222,42 € 28,38 € 24,75 € -12,81%
30-39 8602,58 8583,24 14,36% 11,50% 310,69 € 44,63 € 35,72 € -19,95%
40-49 8482,64 8176,95 14,16% 10,95% 411,76 € 58,32 € 45,10 € -22,66%
50-59 7797,79 7787,49 13,02% 10,43% 770,93 € 100,37 € 80,42 € -19,88%
60-69 5198,12 7813,66 8,68% 10,47% 1084,67 € 94,14 € 113,53 € 20,59%
70-79 4611,94 7219,29 7,70% 9,67% 1592,33 € 122,61 € 153,98 € 25,58%
>79 2665,04 9594,43 4,45% 12,85% 1613,83 € 71,81 € 207,41 € 188,83%
SUM 59893,00 74654,40 100,00% 100,00%   564,13 € 701,73 € 24,39%
  1. Source: Own analysis based on [4, 16].